Annual CFO
-$9.68 M
+$4.19 M+30.22%
01 December 2023
Summary:
NLS Pharmaceutics AG annual cash flow from operations is currently -$9.68 million, with the most recent change of +$4.19 million (+30.22%) on 01 December 2023. During the last 3 years, it has fallen by -$8.96 million (-1227.74%). NLSP annual CFO is now -4997.11% below its all-time high of -$190.00 thousand, reached on 31 December 2019.NLSP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLSP Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +30.2% | - | - |
3 y3 years | -1227.7% | - | - |
5 y5 years | -254.4% | - | - |
NLSP Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -1227.7% | +35.2% | ||||
5 y | 5 years | -4997.1% | +35.2% | ||||
alltime | all time | -4997.1% | +35.2% |
NLS Pharmaceutics AG Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$9.68 M(-30.2%) | - | - |
Dec 2022 | -$13.88 M(-7.1%) | - | - |
Dec 2021 | -$14.94 M(+1947.7%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | -$729.40 K(+283.9%) | - | - |
Dec 2019 | -$190.00 K(-93.0%) | - | - |
Dec 2018 | -$2.73 M(-49.7%) | - | - |
Dec 2017 | -$5.43 M | - | - |
FAQ
- What is NLS Pharmaceutics AG annual cash flow from operations?
- What is the all time high annual CFO for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual CFO year-on-year change?
What is NLS Pharmaceutics AG annual cash flow from operations?
The current annual CFO of NLSP is -$9.68 M
What is the all time high annual CFO for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual cash flow from operations is -$190.00 K
What is NLS Pharmaceutics AG annual CFO year-on-year change?
Over the past year, NLSP annual cash flow from operations has changed by +$4.19 M (+30.22%)